Spain· ES:957700000IP2
TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
A medicinal product containing desfesoterodina, registered in Spain by Ratiopharm Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- desfesoterodina
- Manufacturer
- Ratiopharm Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo76958428EUR 28.32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Desfesoterodina in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Belgium · Tovedeso
- Germany · Tovedeso
- Croatia · Tovedeso
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e143a1ab-3e53-4cb1-b1de-ec18d360c51b GET /v1/drugs/e143a1ab-3e53-4cb1-b1de-ec18d360c51b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1766746621000}",
"nregistro": "957700000IP2",
"substance": "desfesoterodina"
}See everything about desfesoterodina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.